Mode
Text Size
Log in / Sign up

Retinal vascular features are significantly associated with lacunar infarction in a meta-analysis of 7,277 participantsEye Changes Linked to Higher Risk of Lacunar Stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that retinal vascular features are associated with lacunar infarction, but causality remains unconfirmed.

This systematic review and meta-analysis investigated the relationship between retinal vascular features and the risk of lacunar infarction. The analysis included a total sample size of 7,277 participants who presented with lacunar infarction and various retinal vascular features. The study setting was not reported. The primary outcome of interest was the occurrence of lacunar infarction. The exposure of interest comprised specific retinal vascular features, including focal arteriolar narrowing, arteriovenous nicking, retinopathy, and venular dilation. No comparator group was explicitly reported in the provided data, as the analysis focused on the association between these features and the condition. The study design is a meta-analysis, which aggregates data from multiple studies to estimate overall effect sizes.

The meta-analysis yielded significant associations between all examined retinal features and lacunar infarction. Focal arteriolar narrowing demonstrated an odds ratio (OR) of 1.77, with a 95% confidence interval (CI) of 1.14 to 2.74 and a p-value of 0.01. The heterogeneity (I) for this outcome was 81%. Arteriovenous nicking showed an OR of 1.70 (95% CI 1.05-2.76, p = 0.03) with an I of 69%. Retinopathy was associated with an OR of 1.99 (95% CI 1.21-3.25, p = 0.006) and an I of 46%. Venular dilation presented an OR of 1.46 (95% CI 1.11-1.93, p = 0.007) with an I of 56%.

No secondary outcomes were reported in the provided data. Consequently, no specific data regarding adverse events, serious adverse events, discontinuations, or tolerability were available for inclusion. The safety profile of the retinal features themselves is not applicable in the traditional sense of drug or device safety, as these are anatomical or physiological markers. The study did not report data on discontinuations or tolerability related to the exposure.

The results suggest a potential link between retinal microvascular pathology and lacunar stroke risk. However, the evidence linking retinal vascular abnormalities to lacunar infarction has been inconsistent in prior literature, which this systematic evaluation sought to clarify. The findings indicate that retinal imaging could serve as a noninvasive biomarker for identifying individuals at risk of lacunar stroke. This approach may offer a practical method for risk stratification in clinical settings where advanced neuroimaging is not immediately available.

Several methodological limitations must be considered when interpreting these results. Heterogeneity ranged from moderate to high across the included studies. Funnel plot asymmetry suggested potential publication bias for focal arteriolar narrowing, arteriovenous nicking, and retinopathy. No significant bias was detected for venular dilation. These biases may influence the magnitude of the observed effect sizes. Furthermore, the observational nature of the data precludes definitive causal conclusions.

Causality has not been confirmed based on this evidence. Future large-scale, prospective studies are needed to confirm causality and improve clinical translation. The current evidence warrants a systematic evaluation but does not support immediate changes in clinical guidelines without further validation. Questions remain regarding the specific mechanisms linking retinal changes to brain infarction and the optimal timing for retinal screening in stroke prevention protocols.

In summary, this meta-analysis provides evidence of a significant association between retinal vascular features and lacunar infarction. While the data supports the utility of retinal imaging as a biomarker, the lack of confirmed causality and the presence of potential publication bias necessitate a conservative approach. Clinicians should recognize these associations as indicators of risk rather than definitive predictors of individual outcome. Further research is essential to translate these findings into actionable clinical strategies.

This research is important because it explores a simple, non-invasive way to spot people who might be at higher risk for a specific type of stroke. Lacunar infarction is a small stroke that affects deep parts of the brain. By looking at the retina, the back of the eye, doctors can see tiny blood vessels that often mirror the health of vessels in the brain. If these eye vessels look unhealthy, it might signal trouble ahead for the brain. This could help doctors identify patients who need closer monitoring or earlier treatment to prevent a stroke from happening.

The researchers combined data from many different studies to get a clearer picture. They looked at a total of 7,277 participants who already had a lacunar infarction and had their retinal features examined. The study focused on four specific signs in the eye: focal arteriolar narrowing, arteriovenous nicking, retinopathy, and venular dilation. These are changes in the size or shape of the tiny blood vessels in the eye that can be seen during a standard eye exam.

The results showed a clear link between these eye signs and the stroke. People with focal arteriolar narrowing had 77% higher odds of having a lacunar infarction compared to those without this sign. Those with arteriovenous nicking had 70% higher odds. The link was even stronger for retinopathy, where odds increased by nearly 100%. Venular dilation was also linked to a 46% increase in odds. These numbers suggest that if you have these eye changes, your risk of this specific stroke is higher than if your eyes look normal.

There were no safety concerns reported in this analysis because the study looked at existing health records and eye exams rather than testing a new drug or treatment. The researchers did not find any new side effects or harms. Instead, the study highlights the potential value of using eye imaging as a tool to find risk factors early. It is a passive observation of what is already there, so there is no risk to the patient from the study itself.

It is very important not to overreact to these findings. The study is a meta-analysis, which means it combines results from many smaller studies, but it still cannot prove that eye changes cause the stroke. The evidence linking these two things has been inconsistent in the past, and this study confirms a link but does not explain exactly how they are connected. There was also some uncertainty in the data, known as heterogeneity, which means the results varied a bit between different studies. Future large-scale research is needed to confirm these findings and to see if they can be used in real clinical practice.

For patients right now, this means that if you have had a lacunar stroke, your doctor might look at your eyes to understand your risk better. However, this single study should not change your daily life or make you panic. It simply adds to the growing list of clues that help doctors understand stroke risk. Keep your regular check-ups and talk to your doctor about your personal risk factors, rather than focusing only on eye signs.

What this means for you:
Eye changes linked to stroke risk, but this study does not prove cause and effect.

Study Details

Study typeMeta analysis
Sample sizen = 7,277
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
INTRODUCTION: Lacunar infarctions, a subtype of cerebral small vessel disease, arise from occlusion of deep penetrating arterioles and contribute substantially to ischemic stroke burden and long-term disability. Because the retinal microvasculature shares anatomical and physiological features with cerebral arterioles, retinal imaging provides a noninvasive proxy for studying systemic microvascular pathology. Evidence linking retinal vascular abnormalities to lacunar infarction has been inconsistent, warranting systematic evaluation. METHODS: We systematically searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library for studies examining associations between retinal vascular changes and lacunar infarction. The primary outcome was lacunar infarction (confirmed by imaging or clinical diagnosis), while retinal vascular features (focal arteriolar narrowing, arteriovenous nicking, retinopathy, and venular dilation) were analyzed as exposure variables. Odds ratios (ORs) with 95% confidence intervals (CIs) were pooled using a random-effects model. Risk of bias was assessed using the NIH Quality Assessment Tool for Observational Studies. RESULTS: Eight studies (n = 7277 participants) were included. All studies demonstrated good methodological quality based on the NIH Quality Assessment Tool for Observational Studies. Meta-analyses showed significant associations between lacunar infarction and focal arteriolar narrowing (OR = 1.77, 95% CI 1.14-2.74, p = 0.01, I = 81%), arteriovenous nicking (OR = 1.70, 95% CI 1.05-2.76, p = 0.03, I = 69%), retinopathy (OR = 1.99, 95% CI 1.21-3.25, p = 0.006, I = 46%), and venular dilation (OR = 1.46, 95% CI 1.11-1.93, p = 0.007, I = 56%). Heterogeneity ranged from moderate to high and was partly reduced in sensitivity analyses. Funnel plot asymmetry suggested potential publication bias for several parameters, supported by Egger's test (focal arteriolar narrowing p = 0.04; arteriovenous nicking p = 0.041; retinopathy p = 0.032), while no significant bias was detected for venular dilation (p = 0.08). CONCLUSION: Retinal microvascular abnormalities are significantly associated with lacunar infarction, supporting the retina as a window into cerebral small vessel pathology. These findings emphasize the prospective role of retinal imaging as a noninvasive biomarker for identifying individuals at risk of lacunar stroke. Future large-scale, prospective studies are needed to confirm causality and improve clinical translation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.